The Eastern Company (EML)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Cash & Equivalents	9.11	14.01	8.05	10.19	6.17	15.32
Short-Term Investments	-	2.05	0.99	-	-	-
Cash & Short-Term Investments	9.11	16.06	9.03	10.19	6.17	15.32
Cash Growth	-33.70%	77.78%	-11.32%	65.16%	-59.74%	-15.03%
Accounts Receivable	40.24	35.52	34.2	42.89	43.15	31.8
Receivables	40.29	35.8	34.78	43.89	44.18	32.2
Inventory	54.14	55.21	58.4	64.64	62.86	43.12
Prepaid Expenses	4.16	3.48	5.44	6.6	6.94	3.15
Other Current Assets	0.24	5.07	4.58	-	3.52	17.94
Total Current Assets	107.95	115.62	112.24	125.32	123.67	111.74
Property, Plant & Equipment	44.53	41.69	40.59	38.33	39.44	41.62
Goodwill	58.64	58.51	58.58	70.78	72.21	72.22
Other Intangible Assets	11.61	12.71	15.1	24.33	28.27	32.49
Long-Term Deferred Tax Assets	6.61	6.61	2.28	0.49	-	-
Other Long-Term Assets	-	-	22.89	-	-	15.78
Total Assets	229.41	235.31	252.04	261.52	266.33	275.53
Accounts Payable	23.14	19.65	24.55	27.64	29.63	21.31
Accrued Expenses	8.38	15.06	9.16	7.27	9.18	6.84
Current Portion of Long-Term Debt	4.3	3.6	2.87	9.01	7.5	6.44
Current Portion of Leases	4.65	3.83	4.51	3.06	2.66	2.83
Other Current Liabilities	-	2.65	1.64	-	0.58	3.25
Total Current Liabilities	40.47	44.79	42.73	46.98	49.56	40.67
Long-Term Debt	32.12	38.64	41.06	55.14	63.81	82.26
Long-Term Leases	16.28	14.16	13.44	9.2	8.64	9.81
Long-Term Deferred Tax Liabilities	-	-	-	-	1.15	2.9
Other Long-Term Liabilities	0.55	0.55	0.74	0.75	0.67	1.22
Total Liabilities	104.96	114.62	119.56	134.91	151.73	171.22
Common Stock	35.73	35.44	33.95	33.59	32.62	31.5
Retained Earnings	137.58	133.55	144.81	138.99	129.42	122.84
Treasury Stock	-28.46	-26.34	-23.28	-22.54	-20.91	-20.54
Comprehensive Income & Other	-20.4	-21.96	-22.99	-23.41	-26.53	-29.5
Shareholders' Equity	124.45	120.69	132.48	126.61	114.6	104.31
Total Liabilities & Equity	229.41	235.31	252.04	261.52	266.33	275.53
Total Debt	57.35	60.24	61.89	76.4	82.62	101.33
Net Cash (Debt)	-48.24	-44.18	-52.86	-66.21	-76.45	-86.01
Net Cash Per Share	-7.83	-7.11	-8.43	-10.61	-12.21	-13.73
Filing Date Shares Outstanding	6.1	6.14	6.21	6.22	6.25	6.25
Total Common Shares Outstanding	6.1	6.16	6.22	6.22	6.27	6.25
Working Capital	67.47	70.83	69.5	78.33	74.11	71.07
Book Value Per Share	20.41	19.58	21.31	20.35	18.29	16.70
Tangible Book Value	54.21	49.47	58.81	31.5	14.12	-0.41
Tangible Book Value Per Share	8.89	8.03	9.46	5.06	2.25	-0.07
Land	-	0.58	0.74	0.82	1.29	1.3
Buildings	-	7.29	12.21	14.36	16.32	17.14
Machinery	-	48.45	39.74	40.93	39.32	38.55
Order Backlog	-	89.2	77.1	72.5	82.8	64.7

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q